(a)
(b)
(c)

Figure 1: The number of publications found in PubMed, devoted to (a) AML, leukemia, and the two most common human cancers; (b) transcriptome and genome-based AML studies; (c) two the most common high-throughput technologies used in AML studies, microarrays, and next generation sequencing (NGS). The search terms and exact numbers of publications are noted in Supplementary Table 1.